Global Antimicrobial Susceptibility Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Antimicrobial Susceptibility Testing market report explains the definition, types, applications, major countries, and major players of the Antimicrobial Susceptibility Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Zhuhai Dl Biotech

    • Creative Diagnostics

    • Merlin

    • Bioanalyse

    • Bio-Rad

    • BD

    • Thermo Fisher

    • Biomérieux

    • Accelerate Diagnostics

    • Hi-Media

    • Liofilchem

    • Synbiosis

    • Merck Group

    • Alifax

    • Danaher

    By Type:

    • Antibacterial Susceptibility Testing

    • Antifungal Susceptibility Testing

    • Antiparasitic Susceptibility Testing

    • Other Susceptibility Testing

    By End-User:

    • Clinical Diagnostics

    • Drug Discovery and Development

    • Epidemiology

    • Other Applications

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Antimicrobial Susceptibility Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Antimicrobial Susceptibility Testing Outlook to 2028- Original Forecasts

    • 2.2 Antimicrobial Susceptibility Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Antimicrobial Susceptibility Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Antimicrobial Susceptibility Testing Market- Recent Developments

    • 6.1 Antimicrobial Susceptibility Testing Market News and Developments

    • 6.2 Antimicrobial Susceptibility Testing Market Deals Landscape

    7 Antimicrobial Susceptibility Testing Raw Materials and Cost Structure Analysis

    • 7.1 Antimicrobial Susceptibility Testing Key Raw Materials

    • 7.2 Antimicrobial Susceptibility Testing Price Trend of Key Raw Materials

    • 7.3 Antimicrobial Susceptibility Testing Key Suppliers of Raw Materials

    • 7.4 Antimicrobial Susceptibility Testing Market Concentration Rate of Raw Materials

    • 7.5 Antimicrobial Susceptibility Testing Cost Structure Analysis

      • 7.5.1 Antimicrobial Susceptibility Testing Raw Materials Analysis

      • 7.5.2 Antimicrobial Susceptibility Testing Labor Cost Analysis

      • 7.5.3 Antimicrobial Susceptibility Testing Manufacturing Expenses Analysis

    8 Global Antimicrobial Susceptibility Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Antimicrobial Susceptibility Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Antimicrobial Susceptibility Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Antimicrobial Susceptibility Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Antimicrobial Susceptibility Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antibacterial Susceptibility Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antifungal Susceptibility Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antiparasitic Susceptibility Testing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antimicrobial Susceptibility Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinical Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Epidemiology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Applications Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Antimicrobial Susceptibility Testing Market Analysis and Outlook till 2022

    • 10.1 Global Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.2.2 Canada Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.2.3 Mexico Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.2 UK Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.3 Spain Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.4 Belgium Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.5 France Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.6 Italy Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.7 Denmark Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.8 Finland Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.9 Norway Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.10 Sweden Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.11 Poland Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.12 Russia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.3.13 Turkey Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.2 Japan Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.3 India Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.4 South Korea Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.5 Pakistan Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.7 Indonesia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.8 Thailand Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.9 Singapore Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.10 Malaysia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.11 Philippines Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.4.12 Vietnam Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.2 Colombia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.3 Chile Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.4 Argentina Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.5 Venezuela Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.6 Peru Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.5.8 Ecuador Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.6.2 Kuwait Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.6.3 Oman Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.6.4 Qatar Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.7.2 South Africa Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.7.3 Egypt Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.7.4 Algeria Antimicrobial Susceptibility Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Antimicrobial Susceptibility Testing Consumption (2017-2022)

      • 10.8.2 New Zealand Antimicrobial Susceptibility Testing Consumption (2017-2022)

    11 Global Antimicrobial Susceptibility Testing Competitive Analysis

    • 11.1 Zhuhai Dl Biotech

      • 11.1.1 Zhuhai Dl Biotech Company Details

      • 11.1.2 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.1.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Creative Diagnostics

      • 11.2.1 Creative Diagnostics Company Details

      • 11.2.2 Creative Diagnostics Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Creative Diagnostics Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.2.4 Creative Diagnostics Antimicrobial Susceptibility Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Merlin

      • 11.3.1 Merlin Company Details

      • 11.3.2 Merlin Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Merlin Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.3.4 Merlin Antimicrobial Susceptibility Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bioanalyse

      • 11.4.1 Bioanalyse Company Details

      • 11.4.2 Bioanalyse Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bioanalyse Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.4.4 Bioanalyse Antimicrobial Susceptibility Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bio-Rad

      • 11.5.1 Bio-Rad Company Details

      • 11.5.2 Bio-Rad Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bio-Rad Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.5.4 Bio-Rad Antimicrobial Susceptibility Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 BD

      • 11.6.1 BD Company Details

      • 11.6.2 BD Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 BD Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.6.4 BD Antimicrobial Susceptibility Testing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Thermo Fisher

      • 11.7.1 Thermo Fisher Company Details

      • 11.7.2 Thermo Fisher Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Thermo Fisher Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.7.4 Thermo Fisher Antimicrobial Susceptibility Testing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Biomérieux

      • 11.8.1 Biomérieux Company Details

      • 11.8.2 Biomérieux Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Biomérieux Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.8.4 Biomérieux Antimicrobial Susceptibility Testing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Accelerate Diagnostics

      • 11.9.1 Accelerate Diagnostics Company Details

      • 11.9.2 Accelerate Diagnostics Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Hi-Media

      • 11.10.1 Hi-Media Company Details

      • 11.10.2 Hi-Media Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Hi-Media Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.10.4 Hi-Media Antimicrobial Susceptibility Testing Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Liofilchem

      • 11.11.1 Liofilchem Company Details

      • 11.11.2 Liofilchem Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Liofilchem Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.11.4 Liofilchem Antimicrobial Susceptibility Testing Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Synbiosis

      • 11.12.1 Synbiosis Company Details

      • 11.12.2 Synbiosis Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Synbiosis Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.12.4 Synbiosis Antimicrobial Susceptibility Testing Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Merck Group

      • 11.13.1 Merck Group Company Details

      • 11.13.2 Merck Group Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Merck Group Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.13.4 Merck Group Antimicrobial Susceptibility Testing Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Alifax

      • 11.14.1 Alifax Company Details

      • 11.14.2 Alifax Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Alifax Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.14.4 Alifax Antimicrobial Susceptibility Testing Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Danaher

      • 11.15.1 Danaher Company Details

      • 11.15.2 Danaher Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Danaher Antimicrobial Susceptibility Testing Main Business and Markets Served

      • 11.15.4 Danaher Antimicrobial Susceptibility Testing Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Antimicrobial Susceptibility Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Antibacterial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Antifungal Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Antiparasitic Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Other Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Clinical Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Epidemiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Applications Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Antimicrobial Susceptibility Testing Market Analysis and Outlook to 2028

    • 13.1 Global Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.5 France Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.3 India Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Antimicrobial Susceptibility Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Antimicrobial Susceptibility Testing

    • Figure of Antimicrobial Susceptibility Testing Picture

    • Table Global Antimicrobial Susceptibility Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Antimicrobial Susceptibility Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Antibacterial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Antifungal Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Antiparasitic Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Other Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)

    • Figure Global Epidemiology Consumption and Growth Rate (2017-2022)

    • Figure Global Other Applications Consumption and Growth Rate (2017-2022)

    • Figure Global Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Table North America Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure United States Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure Germany Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure UK Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure France Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table APAC Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure China Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure India Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table South America Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure Brazil Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table GCC Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure Bahrain Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table Africa Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure Nigeria Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania Antimicrobial Susceptibility Testing Consumption by Country (2017-2022)

    • Figure Australia Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Antimicrobial Susceptibility Testing Consumption and Growth Rate (2017-2022)

    • Table Zhuhai Dl Biotech Company Details

    • Table Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Product Portfolio

    • Table Creative Diagnostics Company Details

    • Table Creative Diagnostics Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Creative Diagnostics Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Creative Diagnostics Antimicrobial Susceptibility Testing Product Portfolio

    • Table Merlin Company Details

    • Table Merlin Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merlin Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Merlin Antimicrobial Susceptibility Testing Product Portfolio

    • Table Bioanalyse Company Details

    • Table Bioanalyse Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioanalyse Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Bioanalyse Antimicrobial Susceptibility Testing Product Portfolio

    • Table Bio-Rad Company Details

    • Table Bio-Rad Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Bio-Rad Antimicrobial Susceptibility Testing Product Portfolio

    • Table BD Company Details

    • Table BD Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table BD Antimicrobial Susceptibility Testing Product Portfolio

    • Table Thermo Fisher Company Details

    • Table Thermo Fisher Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Thermo Fisher Antimicrobial Susceptibility Testing Product Portfolio

    • Table Biomérieux Company Details

    • Table Biomérieux Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomérieux Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Biomérieux Antimicrobial Susceptibility Testing Product Portfolio

    • Table Accelerate Diagnostics Company Details

    • Table Accelerate Diagnostics Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accelerate Diagnostics Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Accelerate Diagnostics Antimicrobial Susceptibility Testing Product Portfolio

    • Table Hi-Media Company Details

    • Table Hi-Media Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hi-Media Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Hi-Media Antimicrobial Susceptibility Testing Product Portfolio

    • Table Liofilchem Company Details

    • Table Liofilchem Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Liofilchem Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Liofilchem Antimicrobial Susceptibility Testing Product Portfolio

    • Table Synbiosis Company Details

    • Table Synbiosis Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synbiosis Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Synbiosis Antimicrobial Susceptibility Testing Product Portfolio

    • Table Merck Group Company Details

    • Table Merck Group Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Group Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Merck Group Antimicrobial Susceptibility Testing Product Portfolio

    • Table Alifax Company Details

    • Table Alifax Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alifax Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Alifax Antimicrobial Susceptibility Testing Product Portfolio

    • Table Danaher Company Details

    • Table Danaher Antimicrobial Susceptibility Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Antimicrobial Susceptibility Testing Main Business and Markets Served

    • Table Danaher Antimicrobial Susceptibility Testing Product Portfolio

    • Figure Global Antibacterial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antifungal Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiparasitic Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epidemiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Applications Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Table North America Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure China Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Antimicrobial Susceptibility Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Antimicrobial Susceptibility Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.